Stock listing
9OF Stock Price, News, Filings & Events — Biorestorative Therapies, Inc.
Selected listing: 9OF · TRADEGATE · EUR · DE
This page tracks Biorestorative Therapies, Inc.'s 9OF:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 9OF:TRADEGATE. 9OF:TRADEGATE is the stock-level entry point for investors researching Biorestorative Therapies, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biorestorative Therapies, Inc. (BRTX) is a public company based in the United States, focused on developing innovative therapies for various medical conditions. With a market capitalization of approximately $7.39 million, the company aims to advance its research and product offerings in the healthcare sector. BRTX is committed to improving patient outcomes through its specialized therapeutic solutions.
- Ticker
- 9OF:TRADEGATE
- Asset type
- Stock
- Market cap
- $3.7M
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- TRADEGATE
- Currency
- EUR
Biorestorative Therapies, Inc. 9OF:TRADEGATE stock context
This page tracks Biorestorative Therapies, Inc.'s 9OF:TRADEGATE listing on TRADEGATE in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 9OF:TRADEGATE. 9OF:TRADEGATE is the stock-level entry point for investors researching Biorestorative Therapies, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biorestorative Therapies, Inc. (BRTX) is a public company based in the United States, focused on developing innovative therapies for various medical conditions. With a market capitalization of approximately $7.39 million, the company aims to advance its research and product offerings in the healthcare sector. BRTX is committed to improving patient outcomes through its specialized therapeutic solutions.
Latest news from Biorestorative Therapies, Inc.
Braveheart Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
September 8, 2026
BioRestorative Therapies Announces Reverse Stock Split
September 2, 2026
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
June 25, 2026
BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth
June 18, 2026
Kaos Capital Announces Acquisition of 4.9% Stake in BioRestorative Therapies (NASDAQ: BRTX)
May 27, 2026
Biorestorative Therapies, Inc. earnings calls
BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call
November 12, 2025 · Replay with transcript and chapters
BioRestorative Therapies, Inc. (BRTX) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
BioRestorative Therapies, Inc. (BRTX) Q1 2025 Earnings Call
May 14, 2025 · Replay with transcript and chapters
BioRestorative Therapies, Inc. (BRTX) Q4 2024 Earnings Call
March 27, 2025 · Replay with transcript and chapters
BioRestorative Therapies, Inc. (BRTX) Q3 2024 Earnings Call
November 13, 2024 · Replay with transcript and chapters
BioRestorative Therapies, Inc. (BRTX) Q2 2024 Earnings Call
August 13, 2024 · Replay with transcript and chapters
Research Biorestorative Therapies, Inc.
Biorestorative Therapies, Inc. investor report
Review AI stock analysis and investor report context for 9OF:TRADEGATE.
Biorestorative Therapies, Inc. company profile
View the public company page for Biorestorative Therapies, Inc. on 6ix.
Biorestorative Therapies, Inc. news
Read company news and market updates connected to Biorestorative Therapies, Inc..
Biorestorative Therapies, Inc. investor events
Find investor webinars, events, and replay context for Biorestorative Therapies, Inc..
Alternate listings
BRTX:NASDAQ
US · USD
Alternate listing for Biorestorative Therapies, Inc.; the primary context on this page is 9OF:TRADEGATE.
A3C9XF:LSX
DE · EUR
Alternate listing for Biorestorative Therapies, Inc.; the primary context on this page is 9OF:TRADEGATE.
BRTX:BOATS
US · USD
Alternate listing for Biorestorative Therapies, Inc.; the primary context on this page is 9OF:TRADEGATE.
A3C9XF:LS
DE · EUR
Alternate listing for Biorestorative Therapies, Inc.; the primary context on this page is 9OF:TRADEGATE.
9OF:GETTEX
DE · EUR
Alternate listing for Biorestorative Therapies, Inc.; the primary context on this page is 9OF:TRADEGATE.
9OF:FWB
DE · EUR
Alternate listing for Biorestorative Therapies, Inc.; the primary context on this page is 9OF:TRADEGATE.
9OF:MUN
DE · EUR
Alternate listing for Biorestorative Therapies, Inc.; the primary context on this page is 9OF:TRADEGATE.
9OF:SWB
DE · EUR
Alternate listing for Biorestorative Therapies, Inc.; the primary context on this page is 9OF:TRADEGATE.